Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 65162-783

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 65162-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Memantine HCl Extended Release Capsules 1)

Chemical structure diagram of Memantine Hydrochloride, showing its molecular framework with attached amine (NH2) and hydrochloride (HCl) components, including methyl groups (CH3).*

FDA Label Image

Figure 1 (Memantine HCl Extended Release Capsules 2)

Line graph showing mean change from baseline in SIB score over 24 weeks of treatment, comparing Memantine Hydrochloride extended-release 28 mg plus AChEI versus placebo plus AChEI. The graph illustrates clinical improvement and decline with error bars for SEM at multiple time points.*

FDA Label Image

Figure 2 (Memantine HCl Extended Release Capsules 3)

A cumulative percentage of patients graph showing SIB (Severe Impairment Battery) change from baseline comparing Memantine Hydrochloride extended-release 28 mg and placebo, plotted with the cumulative percentage on the vertical axis and SIB change on the horizontal axis. The chart includes distinct markers for Memantine HCl extended-release and placebo groups.*

FDA Label Image

Figure 3 (Memantine HCl Extended Release Capsules 4)

A line graph depicting the mean CIBIC-Plus scores over 24 weeks of treatment comparing Memantine HCl extended-release 28 mg/AChEI and placebo/AChEI groups. The x-axis shows weeks of treatment, and the y-axis shows mean scores, with markers for clinical improvement and decline. Error bars indicate SEM for the data points.*

FDA Label Image

Figure 4 (Memantine HCl Extended Release Capsules 5)

A bar chart comparing the percentage of patients across various CIBIC Plus Rating categories between Memantine Hydrochloride extended-release 28 mg/AChEI and placebo/AChEI groups. Categories include marked improvement, moderate improvement, minimal improvement, no change, minimal worsening, moderate worsening, and marked worsening.*

FDA Label Image

7mg Label (Memantine HCl Extended Release Capsules 6)

Label for Memantine HCl Extended-Release Capsules, 7 mg strength, containing 30 capsules per bottle. The label states it is a once-daily prescription medication distributed by Amneal Pharmaceuticals LLC. It includes storage instructions and an image of a yellow capsule marked with "AN 782."*

FDA Label Image

14mg Label (Memantine HCl Extended Release Capsules 7)

Label for Memantine HCl Extended-Release Capsules 14 mg by Amneal Pharmaceuticals LLC. It indicates the capsules are for once-daily oral use and are prescription only. The package contains 30 capsules. Storage instructions and distributor information are also included.*

FDA Label Image

21mg Label (Memantine HCl Extended Release Capsules 8)

Label for Memantine HCl Extended-Release Capsules, 21 mg strength, oral dosage form. The label indicates a 30-capsule package with a green and white capsule image. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Includes storage instructions and a barcode.*

FDA Label Image

28mg Label (Memantine HCl Extended Release Capsules 9)

Label for Memantine HCl Extended-Release Capsules, 28 mg, by Amneal Pharmaceuticals LLC. The label includes dosage form (extended-release capsules), strength (28 mg), quantity (30 capsules), and storage information. It also displays the NDC 65162-785-03 and a capsule image with imprint AN 786.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.